Sept 02, 2015/IOSCO

The Committee on Payments and Market Infrastructures (CPMI) and the International Organisation of Securities Commissions (IOSCO) said on Wednesday they have published for public comment a consultative report entitled Harmonisation of a first batch of key OTC derivatives data elements (other than Unique Transaction Identifier, UTI, and Unique Product Identifier, UPI). 

G20 Leaders agreed in 2009 that all over-the-counter (OTC) derivatives contracts should be reported to trade repositories (TRs) as part of their commitment to reform OTC derivatives markets with the aim of improving transparency, mitigating systemic risk and preventing market abuse. Aggregation of the data reported across TRs will help ensure that authorities can obtain a comprehensive view of the OTC derivatives market and its activity. The 2012 CPSS-IOSCO Report on OTC derivatives data reporting and aggregation requirements, the 2013 CPSS-IOSCO report on Authorities’ access to trade repository data and the 2014 FSB Feasibility study on approaches to aggregate OTC derivatives data provided the starting point for the harmonisation work on key OTC derivatives data elements for meaningful aggregation on a global basis. Following the 2014 feasibility study, the FSB asked the CPMI and the IOSCO to develop global guidance on the harmonisation of data elements reported to TRs and important for the aggregation of data by authorities including the UTIs and UPIs.

This consultative report is one part of the CPMI-IOSCO Harmonisation Group’s response to its mandate. It focuses on a first batch of key data elements (other than UTI and UPI) that are considered important for consistent and meaningful aggregation on a global basis.